James Baber (J Baber)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Inflammatory Response

Top Venues

Human vaccines & immunotherapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, Ingrid L Scully, Eleni Lagkadinou, Özlem Tureci, Uğur Şahin, Philip R Dormitzer, William C Gruber, Stephen Lockhart
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults. Nature communications 12 (1) (2021)
Megumi Inoue, Takuma Yonemura, James Baber, Yasuko Shoji, Masakazu Aizawa, David Cooper, Joseph Eiden, William C Gruber, Kathrin U Jansen, Annaliesa S Anderson, Alejandra Gurtman
Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults. Human vaccines & immunotherapeutics 14 (11) (2018)
A Gurtman, E Begier, N Mohamed, James Baber, C Sabharwal, R M Haupt, H Edwards, D Cooper, K U Jansen, A S Anderson
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery. Human vaccines & immunotherapeutics 15 (2) (2018)